Please try another search
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Name | Age | Since | Title |
---|---|---|---|
Andrew Grant | - | 2023 | Independent Non-Executive Director |
Janelle Delaney | - | 2023 | Independent Non-Executive Director |
Christine Emmanuel-Donnelly | - | 2023 | Independent Non-Executive Chair |
McGregor Grant | - | 2023 | Interim CFO & Executive Director |
Parmjot Bains | - | 2024 | MD, Interim CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review